Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lance C Pagliaro
Academic and Community Cancer Research United
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
- Sanford Medical Center Fargo
Fargo, North Dakota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Feb 2018
- Primary completion
- 13 Mar 2021
- Completion
- 13 Mar 2021
- Last update posted
- 31 Mar 2022
- Registered enrollment
- 5
- Registry id
- NCT03334409
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.